OLIC (Thailand) Limited
is the largest provider of contract manufacturing services for pharmaceutical, healthcare, confectionary and supplement industries in Thailand and South-East Asia. OLIC was founded in 1984 when Diethelm Holdings (Switzerland) acquired the pharmaceutical assets of Lepetit, the Thailand affiliate of Dow-Chemical Company, located in Sukhumvit area in Bangkok.
Due to its growth and expansion, a new manufacturing plant was built and commissioned in 1997, located in Bangpa-In Industrial Estate, Ayutthaya, on 80,000 sqm of land owned by OLIC.
OLIC has cultivated successful partnerships that last. The company is a trusted partner of more than 30 multinational companies, including most of the Big Pharma organizations. The OLIC Manufacturing facility complies to GMP requirements to the PIC/S guide for Good Manufacturing Practice for Medicinal products. Products made by OLIC are serving not only markets in Thailand and South-East Asia, but also Japan, Australia, US, and Europe.
Contribute to healthy living by supplying outstanding pharmaceuticals and healthcare products. We take pride and pleasure in our involvement with people and appreciate the opportunity to enrich and enhance their quality of life.
To growth of the Company that is proportional to the development of its employees. Our goal is to facilitate the development of our employees as human beings and as leaders, providing them with opportunities for self-realization through our corporate activities.
We aim to contribute to the general improvement of healthcare through the development, production and marketing/sales of pharmaceutical and healthcare products.
Cognizant of the respective circumstances of each client, we strive to create new values by partnering with clients and achieve growth based on this synergy.
HUMAN RESOURCES MANAGEMENT
We place great emphasis on developing employee satisfaction by offering a work environment that is fair and open, as well as ample opportunities to learn and grow, not only as workers but on a private, personal level.
Our goal is to enrich and develop corporate value on a proprietary and sustainable basis by concentrating on our strengths and by engaging in limited realms and in winnable competitive fields.
770 (as of Sep,2020)
+ Subcontractor 14
Over 30 clients
Over 600 products
Fuji Pharma Co., Ltd. (99.9%)